By 2008 some clinical experience with exenatide had been gained by
most diabetologists since its launch in the UK in 2007. ABCD realised that
it was in a unique position to accelerate understanding of this new agent by pooling all the individual experiences of
its many members through a national audit. It considered
what might we learn
from such a national audit and set up a questionnaire on a password
protected subweb of its Sharepoint website for collection of anonymised
national audit went live in December 2008 and the last deadline for data
submission was July 20 2009. The audit collected anonymised data on
6717 patients (2007-2009) submitted by 315 contributors from 126 centres.
Several papers have been published and there
have been many presentations at national and international meetings.
For the latest list of
papers, abstracts, presentations, posters
click here. Access to these is
partial except to ABCD members and contributors to the audit.
Further enquiries may be made to the ABCD
audits database administrator,